XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -34.87%610.58M | -34.87%610.58M | -29.83%983.5M | -38.52%900.81M | -27.81%1.03B | -15.01%937.47M | -15.01%937.47M | 89.15%1.4B | 50.27%1.47B | 75.81%1.43B |
-Cash and cash equivalents | -34.87%610.58M | -34.87%610.58M | -29.83%983.5M | -38.52%900.81M | -27.81%1.03B | -15.01%937.47M | -15.01%937.47M | 89.15%1.4B | 50.27%1.47B | 75.81%1.43B |
Receivables | -0.82%67.95M | -0.82%67.95M | -4.88%64.8M | -0.66%69.63M | -2.90%67.64M | -7.14%68.52M | -7.14%68.52M | 2.93%68.13M | 4.78%70.09M | 14.34%69.66M |
-Accounts receivable | -0.82%67.95M | -0.82%67.95M | -4.88%64.8M | -0.66%69.63M | -2.90%67.64M | -7.14%68.52M | -7.14%68.52M | 2.93%68.13M | 4.78%70.09M | 14.34%69.66M |
Net loan | -9.41%11.86B | -9.41%11.86B | -9.39%11.85B | -8.30%12.31B | -8.28%12.82B | -9.57%13.1B | -9.57%13.1B | -11.10%13.08B | -9.66%13.42B | -3.92%13.98B |
-Gross loan | -9.46%12.06B | -9.46%12.06B | -9.52%12.05B | -8.40%12.52B | -8.29%13.04B | -9.65%13.32B | -9.65%13.32B | -11.08%13.32B | -9.51%13.67B | -3.54%14.22B |
-Allowance for loans and lease losses | -12.34%194.63M | -12.34%194.63M | -16.68%197.4M | -13.63%212M | -8.45%224.66M | -13.80%222.02M | -13.80%222.02M | -10.14%236.93M | -0.69%245.46M | 24.24%245.39M |
Securities and investments | 18.31%3.4B | 18.31%3.4B | -17.04%3.03B | -19.18%3.03B | -25.57%2.87B | -28.06%2.87B | -28.06%2.87B | -9.74%3.65B | -7.87%3.75B | -8.45%3.86B |
-Held to maturity securities | -1.03%1.71B | -1.03%1.71B | -1.40%1.71B | -1.58%1.71B | -1.63%1.72B | 24.60%1.73B | 24.60%1.73B | 25.43%1.74B | 24.95%1.74B | 75.54%1.75B |
-Short term investments | 47.64%1.68B | 47.64%1.68B | -31.24%1.32B | -34.38%1.32B | -45.38%1.15B | -56.17%1.14B | -56.17%1.14B | -28.05%1.91B | -24.91%2.01B | -34.43%2.11B |
Federal home loan bank stock | -1.70%97.54M | -1.70%97.54M | -7.74%97.34M | -7.91%97.04M | -7.98%97.06M | -17.26%99.23M | -17.26%99.23M | -11.17%105.51M | -11.18%105.37M | -9.83%105.48M |
Bank owned life insurance | 2.92%484.95M | 2.92%484.95M | 2.80%481.31M | 2.67%477.69M | 2.52%474.4M | 2.43%471.18M | 2.43%471.18M | 2.38%468.19M | 2.35%465.29M | 2.38%462.73M |
Net PPE | -14.28%48.58M | -14.28%48.58M | -16.14%49.81M | -15.26%52.14M | -13.65%54.79M | -12.19%56.68M | -12.19%56.68M | -9.53%59.4M | -10.09%61.53M | -9.94%63.45M |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 2.69%133.81M | 2.69%133.81M | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -17.30%-77.14M | -17.30%-77.14M | ---- | ---- | ---- |
Foreclosed assets | --0 | --0 | --0 | --0 | -95.49%248K | --248K | --248K | --450K | --270K | --5.5M |
Goodwill and other intangible assets | -1.17%933.51M | -1.17%933.51M | -1.20%936.24M | -1.23%939M | -1.25%941.76M | -1.29%944.6M | -1.29%944.6M | -1.32%947.62M | -1.36%950.67M | -1.40%953.73M |
-Goodwill | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M | 0.00%901.31M |
-Other intangible assets | -25.62%32.19M | -25.62%32.19M | -24.58%34.92M | -23.65%37.69M | -22.83%40.45M | -22.13%43.29M | -22.13%43.29M | -21.55%46.31M | -21.02%49.36M | -20.55%52.42M |
Other assets | -18.35%301.3M | -18.35%301.3M | 3.55%308.12M | 27.56%350.93M | 32.97%341.84M | 45.35%369M | 45.35%369M | 15.77%297.57M | 6.42%275.11M | 5.83%257.08M |
Total assets | -5.90%17.9B | -5.90%17.9B | -11.67%17.91B | -11.64%18.33B | -11.93%18.81B | -12.27%19.03B | -12.27%19.03B | -6.21%20.28B | -5.67%20.75B | -1.21%21.36B |
Liabilities | ||||||||||
Total deposits | -3.55%14.46B | -3.55%14.46B | -9.54%14.48B | -11.56%14.63B | -11.74%15.19B | -13.58%15B | -13.58%15B | -9.80%16.01B | -8.54%16.54B | -2.72%17.21B |
Long term debt and capital lease obligation | -70.76%272.45M | -70.76%272.45M | -75.94%272.32M | -52.97%532.16M | -52.98%532M | -30.00%931.84M | -30.00%931.84M | 21.55%1.13B | 21.55%1.13B | 21.56%1.13B |
-Long term debt | -70.76%272.45M | -70.76%272.45M | -75.94%272.32M | -52.97%532.16M | -52.98%532M | -30.00%931.84M | -30.00%931.84M | 21.55%1.13B | 21.55%1.13B | 21.56%1.13B |
Other liabilities | -2.26%211.69M | -2.26%211.69M | -24.41%212.46M | 9.41%248.75M | -0.35%190.55M | 5.13%216.6M | 5.13%216.6M | 36.18%281.06M | 1.86%227.35M | -12.81%191.23M |
Total liabilities | -7.41%14.95B | -7.41%14.95B | -14.09%14.97B | -13.91%15.41B | -14.14%15.91B | -14.53%16.14B | -14.53%16.14B | -7.75%17.42B | -6.96%17.9B | -1.64%18.53B |
Shareholders'equity | ||||||||||
Share capital | 0.43%942K | 0.43%942K | 0.53%942K | 0.43%941K | 0.43%941K | 0.54%938K | 0.54%938K | 0.43%937K | 0.43%937K | 0.43%937K |
-common stock | 0.43%942K | 0.43%942K | 0.53%942K | 0.43%941K | 0.43%941K | 0.54%938K | 0.54%938K | 0.43%937K | 0.43%937K | 0.43%937K |
-Preferred stock | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Paid-in capital | 0.77%2.4B | 0.77%2.4B | 0.75%2.39B | 0.72%2.38B | 0.69%2.38B | 0.61%2.38B | 0.61%2.38B | 0.60%2.37B | 0.56%2.37B | 0.56%2.36B |
Retained earnings | 5.15%635.27M | 5.15%635.27M | -17.88%633.35M | -16.87%629.34M | -15.28%619.41M | -13.70%604.14M | -13.70%604.14M | 17.24%771.29M | 22.91%757.03M | 26.58%731.12M |
Gains losses not affecting retained earnings | 23.91%-75.81M | 23.91%-75.81M | 72.24%-80.12M | 67.28%-90.13M | 63.57%-95.72M | 62.44%-99.63M | 62.44%-99.63M | -2.67%-288.63M | -28.11%-275.47M | -82.16%-262.73M |
Total stockholders'equity | 2.54%2.96B | 2.54%2.96B | 3.10%2.94B | 2.62%2.92B | 2.53%2.9B | 3.01%2.88B | 3.01%2.88B | 4.39%2.86B | 3.41%2.85B | 1.73%2.83B |
Total equity | 2.54%2.96B | 2.54%2.96B | 3.10%2.94B | 2.62%2.92B | 2.53%2.9B | 3.01%2.88B | 3.01%2.88B | 4.39%2.86B | 3.41%2.85B | 1.73%2.83B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |